Advertisement

Reactions Weekly

, Volume 1658, Issue 1, pp 264–264 | Cite as

Ledipasvir/sofosbuvir

Various toxicities: 10 case reports
Case report

Reference

  1. Morales AL, et al. Ledipasvir/sofosbuvir is effective and well tolerated in postkidney transplant patients with chronic hepatitis C virus. Clinical Transplantation 31: e12941, No. 5, May 2017. Available from: URL: http://doi.org/10.1111/ctr.12941 - USACrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG 2017

Personalised recommendations